Interestingly, CYRI-B (FAM49B) has been originally identified as a suppressor of cancer cell proliferation and invasion in pancreatic ductal adenocarcinoma (PDAC; Chattaragada et al., 2018). Here, CYRIB is linked to pancreatic ductal adenocarcinoma.